Advertisement

Index by author

September 01, 1995; Volume 48,Issue 3

A

  1. Akuzawa, S

    1. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
      A Miyake, S Mochizuki, Y Takemoto and S Akuzawa
      Molecular Pharmacology September 1995, 48 (3) 407-416;

  2. Alojipan, S V

    1. The delta isomer of hexachlorocyclohexane induces rapid release of the myo-inositol-1,4,5-trisphosphate-sensitive Ca2+ store and blocks capacitative Ca2+ entry in rat basophilic leukemia cells.
      F C Mohr, S V Alojipan, S K Dunston and I N Pessah
      Molecular Pharmacology September 1995, 48 (3) 512-522;

  3. Amend, A

    1. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
      X M Guan, A Amend and C D Strader
      Molecular Pharmacology September 1995, 48 (3) 492-498;

B

  1. Ballatori, N

    1. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
      N Ballatori, A T Truong, P S Jackson, K Strange and J L Boyer
      Molecular Pharmacology September 1995, 48 (3) 472-476;

  2. Beall, H D

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

  3. Bezprozvanny, I

    1. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
      I Bezprozvanny and R W Tsien
      Molecular Pharmacology September 1995, 48 (3) 540-549;

  4. Blokhin, A V

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  5. Blond, O

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  6. Bloom, F E

    1. Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2.
      N Yu, D Maciejewski-Lenoir, F E Bloom and P J Magistretti
      Molecular Pharmacology September 1995, 48 (3) 550-558;

  7. Boyer, J L

    1. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
      N Ballatori, A T Truong, P S Jackson, K Strange and J L Boyer
      Molecular Pharmacology September 1995, 48 (3) 472-476;

  8. Boyle, F T

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  9. Briley, E M

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  10. Butler, J

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

C

  1. Chida, N

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

  2. Connelly, P

    1. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
      D G Perregaux, D Dean, M Cronan, P Connelly and C A Gabel
      Molecular Pharmacology September 1995, 48 (3) 433-442;

  3. Conroy, C W

    1. The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV.
      C W Conroy and T H Maren
      Molecular Pharmacology September 1995, 48 (3) 486-491;

  4. Cory, M

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

  5. Cronan, M

    1. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
      D G Perregaux, D Dean, M Cronan, P Connelly and C A Gabel
      Molecular Pharmacology September 1995, 48 (3) 433-442;

D

  1. Daniels, A J

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

  2. Dean, D

    1. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
      D G Perregaux, D Dean, M Cronan, P Connelly and C A Gabel
      Molecular Pharmacology September 1995, 48 (3) 433-442;

  3. Dunston, S K

    1. The delta isomer of hexachlorocyclohexane induces rapid release of the myo-inositol-1,4,5-trisphosphate-sensitive Ca2+ store and blocks capacitative Ca2+ entry in rat basophilic leukemia cells.
      F C Mohr, S V Alojipan, S K Dunston and I N Pessah
      Molecular Pharmacology September 1995, 48 (3) 512-522;

F

  1. Felder, C C

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  2. Filatov, G N

    1. The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.
      G N Filatov and M M White
      Molecular Pharmacology September 1995, 48 (3) 379-384;

  3. Forsch, R A

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

G

  1. Gabel, C A

    1. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
      D G Perregaux, D Dean, M Cronan, P Connelly and C A Gabel
      Molecular Pharmacology September 1995, 48 (3) 433-442;

  2. Galivan, J

    1. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
      R Yao, M S Rhee and J Galivan
      Molecular Pharmacology September 1995, 48 (3) 505-511;

  3. Geralds, R S

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  4. Gerwick, W H

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  5. Griffin, K J

    1. A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.
      M H Hsu, C N Palmer, K J Griffin and E F Johnson
      Molecular Pharmacology September 1995, 48 (3) 559-567;

  6. Guan, X M

    1. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
      X M Guan, A Amend and C D Strader
      Molecular Pharmacology September 1995, 48 (3) 492-498;

H

  1. Hamel, E

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  2. Hargreaves, R H

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

  3. Heyer, D

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

  4. Hirosumi, J

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

  5. Horie, K

    1. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
      K Horie, H Itoh and G Tsujimoto
      Molecular Pharmacology September 1995, 48 (3) 392-400;

  6. Hsu, M H

    1. A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.
      M H Hsu, C N Palmer, K J Griffin and E F Johnson
      Molecular Pharmacology September 1995, 48 (3) 559-567;

  7. Huang, R C

    1. Novel pharmacological properties of transient potassium currents in central neurons revealed by N-bromoacetamide and other chemical modifiers.
      R C Huang
      Molecular Pharmacology September 1995, 48 (3) 451-458;

  8. Hynes, J B

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

I

  1. Itoh, H

    1. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
      K Horie, H Itoh and G Tsujimoto
      Molecular Pharmacology September 1995, 48 (3) 392-400;

J

  1. Jackman, A L

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  2. Jackson, P S

    1. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
      N Ballatori, A T Truong, P S Jackson, K Strange and J L Boyer
      Molecular Pharmacology September 1995, 48 (3) 472-476;

  3. Jenco, J M

    1. Regulation of phosphoinositide-3-kinase by G protein beta gamma subunits in a rat osteosarcoma cell line.
      A J Morris, S A Rudge, C E Mahlum and J M Jenco
      Molecular Pharmacology September 1995, 48 (3) 532-539;

  4. Johnson, E F

    1. A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.
      M H Hsu, C N Palmer, K J Griffin and E F Johnson
      Molecular Pharmacology September 1995, 48 (3) 559-567;

  5. Joyce, K E

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

K

  1. Kathmann, I

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  2. Kemper, B

    1. Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2.
      M Ramarao and B Kemper
      Molecular Pharmacology September 1995, 48 (3) 417-424;

  3. Kojo, H

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

L

  1. Lai, Y

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  2. Leban, J J

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

  3. Logsdon, C D

    1. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
      J Yang, J A Williams, D I Yule and C D Logsdon
      Molecular Pharmacology September 1995, 48 (3) 477-485;

M

  1. Ma, A L

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  2. Maciejewski-Lenoir, D

    1. Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2.
      N Yu, D Maciejewski-Lenoir, F E Bloom and P J Magistretti
      Molecular Pharmacology September 1995, 48 (3) 550-558;

  3. Mackie, K

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  4. Magistretti, P J

    1. Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2.
      N Yu, D Maciejewski-Lenoir, F E Bloom and P J Magistretti
      Molecular Pharmacology September 1995, 48 (3) 550-558;

  5. Mahlum, C E

    1. Regulation of phosphoinositide-3-kinase by G protein beta gamma subunits in a rat osteosarcoma cell line.
      A J Morris, S A Rudge, C E Mahlum and J M Jenco
      Molecular Pharmacology September 1995, 48 (3) 532-539;

  6. Mansouri, J

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  7. Maren, T H

    1. The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV.
      C W Conroy and T H Maren
      Molecular Pharmacology September 1995, 48 (3) 486-491;

  8. Matthews, J E

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

  9. Mitchell, R L

    1. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
      C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma and R L Mitchell
      Molecular Pharmacology September 1995, 48 (3) 443-450;

  10. Miyake, A

    1. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
      A Miyake, S Mochizuki, Y Takemoto and S Akuzawa
      Molecular Pharmacology September 1995, 48 (3) 407-416;

  11. Mochizuki, S

    1. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
      A Miyake, S Mochizuki, Y Takemoto and S Akuzawa
      Molecular Pharmacology September 1995, 48 (3) 407-416;

  12. Mohr, F C

    1. The delta isomer of hexachlorocyclohexane induces rapid release of the myo-inositol-1,4,5-trisphosphate-sensitive Ca2+ store and blocks capacitative Ca2+ entry in rat basophilic leukemia cells.
      F C Mohr, S V Alojipan, S K Dunston and I N Pessah
      Molecular Pharmacology September 1995, 48 (3) 512-522;

  13. Morris, A J

    1. Regulation of phosphoinositide-3-kinase by G protein beta gamma subunits in a rat osteosarcoma cell line.
      A J Morris, S A Rudge, C E Mahlum and J M Jenco
      Molecular Pharmacology September 1995, 48 (3) 532-539;

  14. Murphy, A M

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

N

  1. Nagle, D G

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  2. Nakayama, O

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

  3. Notsu, Y

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

O

  1. Okuhara, M

    1. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
      H Kojo, O Nakayama, J Hirosumi, N Chida, Y Notsu and M Okuhara
      Molecular Pharmacology September 1995, 48 (3) 401-406;

P

  1. Palmer, C N

    1. A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.
      M H Hsu, C N Palmer, K J Griffin and E F Johnson
      Molecular Pharmacology September 1995, 48 (3) 559-567;

  2. Perregaux, D G

    1. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
      D G Perregaux, D Dean, M Cronan, P Connelly and C A Gabel
      Molecular Pharmacology September 1995, 48 (3) 433-442;

  3. Pessah, I N

    1. The delta isomer of hexachlorocyclohexane induces rapid release of the myo-inositol-1,4,5-trisphosphate-sensitive Ca2+ store and blocks capacitative Ca2+ entry in rat basophilic leukemia cells.
      F C Mohr, S V Alojipan, S K Dunston and I N Pessah
      Molecular Pharmacology September 1995, 48 (3) 512-522;

  4. Peters, G J

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  5. Pinedo, H M

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

R

  1. Ramarao, M

    1. Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2.
      M Ramarao and B Kemper
      Molecular Pharmacology September 1995, 48 (3) 417-424;

  2. Rhee, M S

    1. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
      R Yao, M S Rhee and J Galivan
      Molecular Pharmacology September 1995, 48 (3) 505-511;

  3. Rosowsky, A

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  4. Ross, D

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

  5. Rudge, S A

    1. Regulation of phosphoinositide-3-kinase by G protein beta gamma subunits in a rat osteosarcoma cell line.
      A J Morris, S A Rudge, C E Mahlum and J M Jenco
      Molecular Pharmacology September 1995, 48 (3) 532-539;

S

  1. Schornagel, J H

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  2. Siegel, D

    1. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
      H D Beall, A M Murphy, D Siegel, R H Hargreaves, J Butler and D Ross
      Molecular Pharmacology September 1995, 48 (3) 499-504;

  3. Sieghart, W

    1. Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors.
      A Slany, J Zezula, V Tretter and W Sieghart
      Molecular Pharmacology September 1995, 48 (3) 385-391;

  4. Slany, A

    1. Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors.
      A Slany, J Zezula, V Tretter and W Sieghart
      Molecular Pharmacology September 1995, 48 (3) 385-391;

  5. Strader, C D

    1. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
      X M Guan, A Amend and C D Strader
      Molecular Pharmacology September 1995, 48 (3) 492-498;

  6. Strange, K

    1. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
      N Ballatori, A T Truong, P S Jackson, K Strange and J L Boyer
      Molecular Pharmacology September 1995, 48 (3) 472-476;

T

  1. Takemoto, Y

    1. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
      A Miyake, S Mochizuki, Y Takemoto and S Akuzawa
      Molecular Pharmacology September 1995, 48 (3) 407-416;

  2. Tretter, V

    1. Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors.
      A Slany, J Zezula, V Tretter and W Sieghart
      Molecular Pharmacology September 1995, 48 (3) 385-391;

  3. Truong, A T

    1. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
      N Ballatori, A T Truong, P S Jackson, K Strange and J L Boyer
      Molecular Pharmacology September 1995, 48 (3) 472-476;

  4. Tsien, R W

    1. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
      I Bezprozvanny and R W Tsien
      Molecular Pharmacology September 1995, 48 (3) 540-549;

  5. Tsujimoto, G

    1. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
      K Horie, H Itoh and G Tsujimoto
      Molecular Pharmacology September 1995, 48 (3) 392-400;

V

  1. Viveros, O H

    1. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
      A J Daniels, J E Matthews, O H Viveros, J J Leban, M Cory and D Heyer
      Molecular Pharmacology September 1995, 48 (3) 425-432;

W

  1. Westerhof, G R

    1. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
      G R Westerhof, J H Schornagel, I Kathmann, A L Jackman, A Rosowsky, R A Forsch, J B Hynes, F T Boyle, G J Peters and H M Pinedo
      Molecular Pharmacology September 1995, 48 (3) 459-471;

  2. White, M M

    1. The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.
      G N Filatov and M M White
      Molecular Pharmacology September 1995, 48 (3) 379-384;

  3. Williams, J A

    1. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
      J Yang, J A Williams, D I Yule and C D Logsdon
      Molecular Pharmacology September 1995, 48 (3) 477-485;

Y

  1. Yang, J

    1. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
      J Yang, J A Williams, D I Yule and C D Logsdon
      Molecular Pharmacology September 1995, 48 (3) 477-485;

  2. Yao, R

    1. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
      R Yao, M S Rhee and J Galivan
      Molecular Pharmacology September 1995, 48 (3) 505-511;

  3. Yoo, H D

    1. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
      A V Blokhin, H D Yoo, R S Geralds, D G Nagle, W H Gerwick and E Hamel
      Molecular Pharmacology September 1995, 48 (3) 523-531;

  4. Yu, N

    1. Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2.
      N Yu, D Maciejewski-Lenoir, F E Bloom and P J Magistretti
      Molecular Pharmacology September 1995, 48 (3) 550-558;

  5. Yule, D I

    1. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
      J Yang, J A Williams, D I Yule and C D Logsdon
      Molecular Pharmacology September 1995, 48 (3) 477-485;

Z

  1. Zezula, J

    1. Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors.
      A Slany, J Zezula, V Tretter and W Sieghart
      Molecular Pharmacology September 1995, 48 (3) 385-391;
Back to top

In this issue